Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07196059 · ClinicalTrials.gov registry record · NA
Assessment of Delphinol® Dose on Vascular Function
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07196059 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 10 participants.
The verdict
NCT07196059, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Maqui berry standardized extract (e.g. Delphinol®) has been used with success to modulate blood glucose and associated variables at a dosage of 450mg daily. Lower dosages have also been used with favorable effects. However, it is unknown what dosage is optimal for positively impacting vascular function. The purpose of this study is to determine the impact of Maqui berry standardized extract (e.g. Delphinol®) at varying dosages on vascular function assessed using the perfusion index, Vendys, and blood nitrate/nitrite concentrations.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Delphinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-03-05 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07196059
The ClinicalTrials.gov registry entry for NCT07196059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07196059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07196059 about?
NCT07196059 is a clinical study titled "Assessment of Delphinol® Dose on Vascular Function". Maqui berry standardized extract (e.g. Delphinol®) has been used with success to modulate blood glucose and associated variables at a dosage of 450mg daily. Lower dosages have also been used with favorable effects. However, it is unknown what dosage is optimal for positively impacting vascular funct...
What is the current status of trial NCT07196059?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-03-05. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT07196059?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Delphinol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07196059?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.